PRESS RELEASE published on 09/25/2025 at 18:00, 2 months 9 days ago THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2025 Theranexus publie ses résultats semestriels pour la période se terminant le 30 juin 2025, mettant en avant la réduction des charges d'exploitation et les projets en cours. Prochaine publication financière le 23 octobre 2025 Résultats Semestriels Développement Trésorerie Theranexus Charges D'exploitation
BRIEF published on 07/17/2025 at 18:05, 4 months 18 days ago Half-Yearly Review of the Theranexus Liquidity Contract Liquidity Contract PORTZAMPARC Financial Statement Biopharmaceuticals Theranexus
BRIEF published on 07/17/2025 at 18:05, 4 months 18 days ago Bilan Semestriel du Contrat de Liquidité de Theranexus Contrat De Liquidité PORTZAMPARC Bilan Financier Biopharmaceutique Theranexus
PRESS RELEASE published on 07/17/2025 at 18:00, 4 months 18 days ago BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC Theranexus publie son bilan semestriel de contrat de liquidité confié à Portzamparc. Retraits, négociations de titres et information sur la société Contrat De Liquidité PORTZAMPARC Biopharmaceutique Theranexus Neurologiques
BRIEF published on 07/10/2025 at 18:05, 4 months 25 days ago Theranexus Dévoile sa Position de Trésorerie au 30 Juin 2025 Trésorerie Theranexus Batten-1 Innovation Biopharmaceutique Maladies Neurologiques
BRIEF published on 07/10/2025 at 18:05, 4 months 25 days ago Theranexus Reveals its Cash Position as of June 30, 2025 Treasury Biopharmaceutical Innovation Theranexus Batten-1 Neurological Diseases
PRESS RELEASE published on 07/10/2025 at 18:00, 4 months 25 days ago THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025 Theranexus, a biopharmaceutical company, reports a cash position of €2.1M as of 30 June 2025, with upcoming funds and financial visibility through Q2 2026. CEO discusses collaborations and strategic progress. H1 2025 results expected on September 25, 2025 Cash Position Biopharmaceutical Financial Publication Theranexus Rare Neurological Diseases
PRESS RELEASE published on 07/10/2025 at 18:00, 4 months 25 days ago THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2025 Theranexus communique sa trésorerie au 30 juin 2025. Récapitulant sa situation financière, la société biopharmaceutique met en avant ses projets innovants en neurologie Innovation Trésorerie Theranexus Neurologie Rareté
BRIEF published on 05/13/2025 at 18:05, 6 months 22 days ago Theranexus et BBDF révèlent des résultats prometteurs pour le Batten-1 Theranexus Batten-1 Maladie De Batten BBDF Acuité Visuelle
BRIEF published on 05/13/2025 at 18:05, 6 months 22 days ago Theranexus and BBDF reveal promising results for Batten-1 Theranexus Batten-1 BBDF Batten Disease Visual Acuity
Published on 12/05/2025 at 02:35, 8 hours 58 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 33 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 28 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 33 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 11:08, 24 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 10:30, 1 hour 3 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 18 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 52 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 08:45, 2 hours 48 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 48 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 2 hours 50 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 18 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 33 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025